Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This was a study to compare less intense immunosuppression with a more traditional approach.
The hypothesis was that less immunosuppression will provide similar protection against
rejection than typical 2-3 drug therapy.